Genetic Technologies Announces Comprehensive Review of Strategic Alternatives
25 août 2017 05h30 HE
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Aug 25, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, and...
Genetic Technologies Launches Breast Cancer Awareness Month Promotion for BREVAGenplus(R)
01 août 2017 08h30 HE
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Aug 1, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company specialising in cancer genomics, and provider...
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2017
27 juil. 2017 19h41 HE
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jul 27, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE)
HIGHLIGHTS
Revised BREVAGenplus® commercial...
Genetic Technologies Receives Nasdaq Deficiency Notice
21 juil. 2017 21h57 HE
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jul 21, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), today announced that on 20 July 2017, it received a notification letter (the...
Genetic Technologies Revamps Patient Pricing and Billing Program for BREVAGenplus(R)
31 mars 2017 05h30 HE
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Mar 31, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, and...
Genetic Technologies and IndyCar's Pippa Mann Partner for Second Consecutive Year to Promote BREVAGenplus(R)
29 mars 2017 05h30 HE
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Mar 29, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, announced...
Genetic Technologies Announces Offering of USD 6.0 Million of American Depository Shares
01 déc. 2016 09h07 HE
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Dec 1, 2016) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company and provider of BREVAGenplus®, a...
Genetic Technologies Limited and The University of Melbourne Enter into Exclusive Worldwide License Agreement to Develop Colorectal Cancer Risk Assessment Test
29 nov. 2016 05h30 HE
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Nov 29, 2016) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company and provider of BREVAGenplus®, a...
Nohla Therapeutics Signs Exclusive Supply Agreement With LifeSouth Community Blood Centers
19 oct. 2016 05h30 HE
|
Nohla Therapeutics
SEATTLE, WA--(Marketwired - Oct 19, 2016) - Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening...
Genetic Technologies Launches BREVAGenplus(R) Marketing Program Around Susan G. Komen(R)'s Race for the Cure(R) Events
03 oct. 2016 05h30 HE
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Oct 3, 2016) - Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") announced today that it will be conducting a...